Thomas Ferguson
Impact in
-
- Renal cell carcinoma treatment
- Cancer Research top 10%
- Cancer Genomics and Diagnostics
- Breast Cancer Treatment Studies
Papers in
-
- Renal cell carcinoma treatment 9
- Oncology 6
- Cancer Treatment and Pharmacology 2
- Bone health and treatments 2
- Cancer Immunotherapy and Biomarkers 1
- Co-authors
- Davina Ghersi (3 shared papers)Anna K. Nowak (5 shared papers)Nicholas Wilcken (3 shared papers)Melina L Willson (1 shared paper)Miguel Ángel Climent (3 shared papers)Xiang Peng (1 shared paper)Louis Lacombe (3 shared papers)Ian Smith (1 shared paper)
- Journals
- Cochrane Database of Systematic Reviews (4 papers)Journal of Clinical Oncology (2 papers)The Oncologist (2 papers)European Urology (2 papers)The Lancet Oncology (2 papers)
- Partner nations
- AustraliaUnited StatesCanada
In The Last Decade
Thomas Ferguson
16 papers receiving 1.2k citations
Thomas Ferguson's Hit Papers
Peers
Comparison fields: 5 of 65
- Pulmonary and Respiratory Medicine 651
- Cancer Research 258
- Oncology 447
- Surgery 175
- Molecular Biology 212
Countries citing papers authored by Thomas Ferguson
This map shows the geographic impact of Thomas Ferguson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Ferguson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Ferguson more than expected).
Fields of papers citing papers by Thomas Ferguson
This network shows the impact of papers produced by Thomas Ferguson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Ferguson. The network helps show where Thomas Ferguson may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas Ferguson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell Carcinoma Hit paper breakdown → | 2021 | 547 |
| 2 | Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for clear cell renal cell carcinoma (KEYNOTE-564): 30-month follow-up analysis of a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial Hit paper breakdown → | 2022 | 210 |
| 3 | 2007 | 158 | |
| 4 | Pembrolizumab plus lenvatinib as first-line therapy for advanced non-clear-cell renal cell carcinoma (KEYNOTE-B61): a single-arm, multicentre, phase 2 trial Hit paper breakdown → | 2023 | 113 |
| 5 | 2019 | 69 | |
| 6 | 2012 | 56 | |
| 7 | 2024 | 17 | |
| 8 | 2023 | 16 | |
| 9 | 2024 | 4 | |
| 10 | 2024 | 4 | |
| 11 | 2007 | 3 | |
| 12 | 2021 | 2 | |
| 13 | 2025 | 2 | |
| 14 | 2026 | 2 | |
| 15 | 2009 | 1 | |
| 16 | 2018 | 1 | |
| 17 | 2024 | 0 | |
| 18 | 2025 | 0 |
About Thomas Ferguson
Thomas Ferguson is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Cancer Research, Orthopedics and Sports Medicine and Surgery, having authored 18 papers that have together received 1.2k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (9 papers), Breast Cancer Treatment Studies (3 papers), Bladder and Urothelial Cancer Treatments (2 papers), Bone health and osteoporosis research (2 papers), Cancer Treatment and Pharmacology (2 papers), Bone health and treatments (2 papers), Cancer Immunotherapy and Biomarkers (1 paper) and Renal and related cancers (1 paper). The work is most often cited by research in Pulmonary and Respiratory Medicine (651 citations), Cancer Research (258 citations), Oncology (447 citations), Surgery (175 citations) and Molecular Biology (212 citations). Thomas Ferguson has collaborated with scholars based in Australia, United States and Canada. Frequent co-authors include Davina Ghersi, Anna K. Nowak, Nicholas Wilcken, Melina L Willson, Miguel Ángel Climent, Xiang Peng, Louis Lacombe, Ian Smith, Laurence K. Albiges and David William Pook. Their work appears in journals such as Cochrane Database of Systematic Reviews, Journal of Clinical Oncology, The Oncologist, European Urology and The Lancet Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.